-
Schepens MHJ, Leusink M, de Vries SE, et al. NTVG. 2019;163:6-16.
-
Dahan A, Kramers C, Schellekens A, et al. Medisch Contact. 2018;47:22-23.
-
Kalkman GA, Kramers C, van Dongen RT, et al. Lancet. 2019;4(10):e498-e505.
-
De Jong L, Keizer P, Köke A, et al. NHG-Standaard Pijn. 2018a Nederlands Huisartsen Genootschap.
-
American Pain Society. Pain: Current Understanding of Assessment, Management, and Treatments. 2001.
-
Gaaker MI, Vleugelers R, Houser CM, et al. NTVG. 2010;154:A2241.
-
Brock C, Olesen SS, Olesen AE, et al. Drugs. 2012;72(14):1847-1865.
-
Holzer P. Am J Gastroenterol Suppl. 2014; 2:9–16.
-
Holzer P. Expert Opin Investig Drugs. 2007;16(2):181-94.
-
Schumacher MA, Basbaum A, Naidu RK. Basic and Clinical Pharmacology. Chapter 31: Opioid Agonists & Antagonists. 2015.
-
Freye E. Opioids in medicine: a comprehensive review on the mode of action and the use of analgesics in different clinical pain states. 2010.
-
Hyldahl S, Gronlund D, Drewes AM, et al. Clin Pract. 2018;15(4):769-778.
-
Pasternak GW, Abbadie C. Opioid Receptor Localization. In: Gebhart GF, Smidt RF, et al. Encyclopedia of Pain. 2013. p2437.
-
Mordecai L, Reynolds C, Donaldson LJ, et al. Br J Gen Pract. 2018;68(668):e225-e233.
-
Eerste Kamerbrief Blokhuis, gebruik oxycodon in Nederland, 8-2-2018.
-
Ekhtiari H, Rezapour T, Aupperle RL, et al. Prog Brain Res. 2017;235:239-264.
-
De Graeff A, Besse TC, Krol TJA. Landelijke richtlijn Pijn. Oncoline. 2010;versie: 2.1.
-
-
Bell TJ, Panchal SJ, Miaskowski C, et al. Pain Medicine. 2009;10(1):35-42.
-
Freye E, Levy JV. Use of potent opioids for chronic pain management. In: freye E, levy JV. Opioids in medicine: A comprehensive review on the mode of action and the use of analgesics in different clinical pain states. 2008.
-
Inturrisi CE. Clin J pain. 2002;(4)18:s3-s13.
-
Wells N, Pasero C, mcCaffery M. Improving the quality of care through pain assessment and management. In: hughes RG ed. Patient safety and quality: an evidence-based handbook for nurses. Rockville, MD: agency for healthcare research and quality. 2008;Ch 17.
-
Benyamin R, Trescot AM, Datta S, et al. Pain physician. 2008;11(suppl 2):S105-S120.
-
Twycross R, Greaves MW, Handwerker H, et al. QJM. 2003;96(1):7-26.
-
Farmer AD, Holt CB, Downes TJ, et al. Lancet Gastroenterol Hepatol 2018;3:203-212.
-
Pannemans J, Vanuytsel T, Tack J. United European Gastroenterol J. 2018;6(8):1126-1135.
-
Mearin F, Lacy BE, Chang L, et al. Gastroenterology 2016;1501393-1407.
-
Akkermans LMA. De Hersenen in de darm. Oratie 1989.
-
Khurana I, Khurana A, Kowlgi NG. Medical Physiology, 3rd Edition Regulation of Gastrointestinal Function. Elsevier. 2019.
-
Drewes AM. Scandinavian Journal of Pain 2017; 15:81-82.
-
Farmer AD, Drewes AM, Chiarioni G, et al. United European Gastroenterology J. 2019;7(1):7-20.
-
Rauck RL, Hong KJ, North J. Pain Pract. 2017;17(3):329-335.
-
Diemel JM, Van den Hurk APJM, Muris JWM, et al. NHG-Standaard Obstipatie. Huisarts Wet 2010;53(9):484-98.
-
Coyne KS, LoCasale RJ, Datto CJ, et al. Clinicoecon Outcomes Res. 2014;6:269-281.
-
LoCasale RJ, Datto C, Margolis MK, et al. J Manag Care Spec Pharm. 2016;22(3):246-253.
-
De Groot JWB , Peters FTM, Reyners AKL. NTVG. 2010;154:A2224.
-
Lewis SJ, Heaton KW. Scandinavian Journal of Gastroenterology.1997;32(9):920-924.
-
-
SPC Relistor, augustus 2009.
-
SPC Moventig, juni 2019.
-
Lacy BE, Mearin F, Chang L, et al. Gastroenterology. 2016;150:1393-1407.
-
Benninga MA, Koppen IJN, Smout AJPM, et al. Het obstipatie formularium 2. Houten: Springer Healthcare. 2018.
-
De Graeff A, Krol RJA. De richtlijn Obstipatie. Pallialine. Versie 2, 2009.
-
SPC Targinact, december 2013.
-
SPC Resolor, oktober 2009.
-
SPC Constella, augustus 2017.
-
SPC Rizmoic, februari 2019.
-
De Koning C, Van Esschoten N. (H)erkenning OIC* is noodzakelijk, bijlage Medisch Contact nummer 50. 2019.
FTO Onderwerpen
FTO
